Literature DB >> 18792974

Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3).

Joanna Bernaciak1, Krzysztof Szczałuba, Katarzyna Derwińska, Barbara Wiśniowiecka-Kowalnik, Ewa Bocian, Maria Małgorzata Sasiadek, Izabela Makowska, Paweł Stankiewicz, Robert Smigiel.   

Abstract

Clinical manifestations of Jacobsen syndrome (JBS) depend on the size of the 11qter deletion, which usually varies between approximately 7 and 20 Mb. Typical JBS features include developmental delay/mental retardation, short stature, congenital heart defects, thrombocytopenia, and characteristic dysmorphic facial features. We report on a family in which a 4-year-old girl as well as her mother and maternal uncle present with subtle features of JBS. Notably, neither thrombocytopenia nor congenital anomalies were detected in this family. Cytogenetic analyses revealed normal karyotypes. Using fluorescence in situ hybridization (FISH) and whole-genome oligonucleotide array CGH analyses, we identified an approximately 5 Mb deletion of the terminal part of chromosome 11q in all the three affected family members. The deletion breakpoint was mapped between 129,511,419 and 129,519,794 bp. This is the smallest deletion reported in a JBS patient. Interestingly, the FLI1 (friend leukemia virus integration 1) hematopoiesis factor gene located approximately 6.5 Mb from 11qter and usually deleted in patients with JBS, is intact. Our data support previous hypotheses that FLI1 haploinsufficiency is responsible for thrombocytopenia in patients with JBS. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18792974     DOI: 10.1002/ajmg.a.32490

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  First Report of Jacobsen Syndrome with Dextrocardia Diagnosed with del(11)(q24q25).

Authors:  Sinem Yalcintepe; Drenushe Zhuri; Hazal Sezginer Guler; Engin Atli; Selma Demir; Emine Ikbal Atli; Cisem Mail; Hakan Gurkan
Journal:  Mol Syndromol       Date:  2022-02-01

2.  Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders.

Authors:  Barbara Wiśniowiecka-Kowalnik; Monika Kastory-Bronowska; Magdalena Bartnik; Katarzyna Derwińska; Wanda Dymczak-Domini; Dorota Szumbarska; Ewa Ziemka; Krzysztof Szczałuba; Maciej Sykulski; Tomasz Gambin; Anna Gambin; Chad A Shaw; Tadeusz Mazurczak; Ewa Obersztyn; Ewa Bocian; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2012-10-03       Impact factor: 4.246

3.  Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation.

Authors:  Ye Wu; Taoyun Ji; Jingmin Wang; Jing Xiao; Huifang Wang; Jie Li; Zhijie Gao; Yanling Yang; Bin Cai; Liwen Wang; Zhongshu Zhou; Lili Tian; Xiaozhu Wang; Nan Zhong; Jiong Qin; Xiru Wu; Yuwu Jiang
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

4.  Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice.

Authors:  Maoqing Ye; Chris Coldren; Xingqun Liang; Teresa Mattina; Elizabeth Goldmuntz; D Woodrow Benson; Dunbar Ivy; M B Perryman; Lee Ann Garrett-Sinha; Paul Grossfeld
Journal:  Hum Mol Genet       Date:  2009-11-26       Impact factor: 6.150

5.  Terminal deletion of 11q with significant late-onset combined immune deficiency.

Authors:  Mikko Seppänen; Hannele Koillinen; Satu Mustjoki; Mölkänen Tomi; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2014-01       Impact factor: 8.317

6.  Jacobsen Syndrome: Surgical Complications due to Unsuspected Diagnosis, the Importance of Molecular Studies in Patients with Craniosynostosis.

Authors:  Etzalli P Linares Chávez; Jaime Toral López; Juan M Valdés Miranda; Luz M González Huerta; Adrian Perez Cabrera; María Del Refugio Rivera Vega; Olga M Messina Baas; Sergio A Cuevas-Covarrubias
Journal:  Mol Syndromol       Date:  2015-12-18

Review 7.  Jacobsen syndrome.

Authors:  Teresa Mattina; Concetta Simona Perrotta; Paul Grossfeld
Journal:  Orphanet J Rare Dis       Date:  2009-03-07       Impact factor: 4.123

8.  Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome).

Authors:  Emmanouil Manolakos; Sandro Orru; Rosita Neroutsou; Konstantinos Kefalas; Eirini Louizou; Ioannis Papoulidis; Loretta Thomaidis; Panagiotis Peitsidis; Sotirios Sotiriou; George Kitsos; Panagiota Tsoplou; Michael B Petersen; Aikaterini Metaxotou
Journal:  Mol Cytogenet       Date:  2009-12-09       Impact factor: 2.009

9.  Evidence for autism spectrum disorder in Jacobsen syndrome: identification of a candidate gene in distal 11q.

Authors:  Natacha Akshoomoff; Sarah N Mattson; Paul D Grossfeld
Journal:  Genet Med       Date:  2014-07-24       Impact factor: 8.822

10.  The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.

Authors:  Virgil A S H Dalm; Gertjan J A Driessen; Barbara H Barendregt; Petrus M van Hagen; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2015-11-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.